Crescent Grove Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49,030
Closed -$1.19M 318
2025
Q4
$1.19M Sell
49,030
-9,215
-16% -$223K 0.11% 115
2025
Q3
$1.42M Sell
58,245
-2,567
-4% -$62.2K 0.13% 97
2025
Q2
$1.47M Sell
60,812
-15,951
-21% -$385K 0.14% 92
2025
Q1
$1.86M Sell
76,763
-430
-0.6% -$10.4K 0.19% 77
2024
Q4
$1.86M Hold
77,193
0.18% 80
2024
Q3
$1.88M Buy
77,193
+9,125
+13% +$220K 0.19% 81
2024
Q2
$1.62M Buy
68,068
+11,686
+21% +$278K 0.18% 83
2024
Q1
$1.34M Hold
56,382
0.14% 99
2023
Q4
$1.35M Buy
56,382
+39,158
+227% +$919K 0.15% 92
2023
Q3
$402K Buy
+17,224
New +$403K 0.05% 195

Other funds holding IBDR

Crescent Grove Advisors's IBDR Position: Q1 2026 in Review

Crescent Grove Advisors sold out of iShares iBonds Dec 2026 Term Corporate ETF (IBDR) in Q1 2026, closing a stake of 49,030 shares — an estimated $1.19M sold.

Crescent Grove Advisors first reported a position in IBDR in Q3 2023 and held it in 10 quarters. The position peaked at $1.88M in Q3 2024. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

  • Crescent Grove Advisors reported no remaining iShares iBonds Dec 2026 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • Crescent Grove Advisors sold 49,030 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $1.19M.
  • Crescent Grove Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q3 2023 and held it in 10 quarters.
  • Crescent Grove Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $1.88M in Q3 2024.
  • 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.